Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Altman

Showing results (491-500 of 514) with videos related to

Pageof 52
Sort By:
Elife|November 2, 2019
Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteinsDavid W Morgens, Charlene Chan, Andrew J Kane, et al.
Nature Machine Intelligence|September 25, 2025
Toward a framework for risk mitigation of potential misuse of artificial intelligence in biomedical researchArtem A Trotsyuk, Quinn Waeiss, Raina Talwar Bhatia, et al.
Journal of the American Chemical Society|February 18, 2015
Covalency in lanthanides. An X-ray absorption spectroscopy and density functional theory study of LnCl6(x-) (x = 3, 2)Matthias W Löble, Jason M Keith, Alison B Altman, et al.
Science Translational Medicine|July 31, 2020
Scientific considerations for global drug developmentJennifer L Wilson, Kit Wun Kathy Cheung, Lawrence Lin, et al.
Nature Genetics|October 19, 2023
Integrative analyses highlight functional regulatory variants associated with neuropsychiatric diseasesMargaret G Guo, David L Reynolds, Cheen E Ang, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
The pharmacogenetics research network: from SNP discovery to clinical drug responseK M Giacomini, C M Brett, R B Altman, et al.
Translational Psychiatry|April 22, 2015
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment responseJ M Biernacka, K Sangkuhl, G Jenkins, et al.
Nature|April 25, 2014
Guidelines for investigating causality of sequence variants in human diseaseD G MacArthur, T A Manolio, D P Dimmock, et al.
JAMA|March 13, 2014
Clinical interpretation and implications of whole-genome sequencingFrederick E Dewey, Megan E Grove, Cuiping Pan, et al.
Clinical Pharmacology and Therapeutics|January 17, 2017
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare SystemsJ A Luzum, R E Pakyz, A R Elsey, et al.
Pageof 52

Showing results (491-500 of 514) with videos related to

Sort By:
Pageof 52
Elife|November 2, 2019
Retro-2 protects cells from ricin toxicity by inhibiting ASNA1-mediated ER targeting and insertion of tail-anchored proteinsDavid W Morgens, Charlene Chan, Andrew J Kane, et al.
Nature Machine Intelligence|September 25, 2025
Toward a framework for risk mitigation of potential misuse of artificial intelligence in biomedical researchArtem A Trotsyuk, Quinn Waeiss, Raina Talwar Bhatia, et al.
Journal of the American Chemical Society|February 18, 2015
Covalency in lanthanides. An X-ray absorption spectroscopy and density functional theory study of LnCl6(x-) (x = 3, 2)Matthias W Löble, Jason M Keith, Alison B Altman, et al.
Science Translational Medicine|July 31, 2020
Scientific considerations for global drug developmentJennifer L Wilson, Kit Wun Kathy Cheung, Lawrence Lin, et al.
Nature Genetics|October 19, 2023
Integrative analyses highlight functional regulatory variants associated with neuropsychiatric diseasesMargaret G Guo, David L Reynolds, Cheen E Ang, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
The pharmacogenetics research network: from SNP discovery to clinical drug responseK M Giacomini, C M Brett, R B Altman, et al.
Translational Psychiatry|April 22, 2015
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment responseJ M Biernacka, K Sangkuhl, G Jenkins, et al.
Nature|April 25, 2014
Guidelines for investigating causality of sequence variants in human diseaseD G MacArthur, T A Manolio, D P Dimmock, et al.
JAMA|March 13, 2014
Clinical interpretation and implications of whole-genome sequencingFrederick E Dewey, Megan E Grove, Cuiping Pan, et al.
Clinical Pharmacology and Therapeutics|January 17, 2017
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare SystemsJ A Luzum, R E Pakyz, A R Elsey, et al.
Pageof 52